Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation

Published:2019-10-18 Issue:20 Volume:3 Page:3013-3019
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Henden Andrea S.¹²³^ORCID,Varelias Antiopi²^ORCID,Leach Justine¹,Sturgeon Elise¹,Avery Judy¹,Kelly Jessica¹,Olver Stuart²,Samson Luke²,Hartel Gunter⁴^ORCID,Durrant Simon¹,Butler Jason¹,Morton Anthony J.¹,Misra Ashish¹,Tey Siok-Keen¹²^ORCID,Subramoniapillai Elango¹,Curley Cameron¹,Kennedy Glen¹,Hill Geoffrey R.¹²⁵⁶

Affiliation:

1. Department of Haematology and Bone Marrow Transplantation, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia;

2. Bone Marrow Transplantation Laboratory, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Brisbane, QLD, Australia;

3. Faculty of Medicine, University of Queensland, Herston, QLD, Australia;

4. Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia;

5. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and

6. Division of Medical Oncology, The University of Washington, Seattle, WA

Abstract

Key Points Peg-IFNα is tolerated and induces disease response in patients who relapse after allogeneic SCT. Increased pretreatment MAIT and pDC proportions were associated with better progression-free and overall survival after peg-IFNα treatment.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/3/20/3013/1257683/advancesadv2019000453.pdf

Reference21 articles.

1. Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT): Summary CBIMTR Slides;D’Souza

2. Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state;Schietinger;Science,2012

3. CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation;Maury;Sci Transl Med,2010

4. Immunotherapy following relapse of acute leukaemia after T-cell-replete allogeneic peripheral blood progenitor cell transplantation: importance of new onset chronic graft-versus-host disease;Curley;Int J Lab Hematol,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune control in acute myeloid leukemia;Experimental Hematology;2024-10

2. Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect;Frontiers in Immunology;2024-03-20

3. The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy;Frontiers in Immunology;2024-03-15

4. Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation;Nature Cancer;2024-01-03

5. Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis;Frontiers in Immunology;2023-02-02